GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Y-Biologics Inc (XKRX:338840) » Definitions » Long-Term Debt

Y-Biologics (XKRX:338840) Long-Term Debt : ₩500 Mil (As of Mar. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Y-Biologics Long-Term Debt?

Y-Biologics's Long-Term Debt for the quarter that ended in Mar. 2024 was ₩500 Mil.

Y-Biologics's quarterly Long-Term Debt stayed the same from Sep. 2023 (₩500 Mil) to Dec. 2023 (₩500 Mil) and stayed the same from Dec. 2023 (₩500 Mil) to Mar. 2024 (₩500 Mil).

Y-Biologics's annual Long-Term Debt declined from Dec. 2020 (₩4,864 Mil) to Dec. 2021 (₩2,528 Mil) and declined from Dec. 2021 (₩2,528 Mil) to Dec. 2022 (₩0 Mil).

Y-Biologics Long-Term Debt Historical Data

The historical data trend for Y-Biologics's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Y-Biologics Long-Term Debt Chart

Y-Biologics Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Long-Term Debt
Get a 7-Day Free Trial 2,864.31 4,864.31 4,864.31 2,528.19 -

Y-Biologics Quarterly Data
Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Long-Term Debt Get a 7-Day Free Trial Premium Member Only - - 500.00 500.00 500.00

Y-Biologics  (XKRX:338840) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

Y-Biologics Long-Term Debt Related Terms

Thank you for viewing the detailed overview of Y-Biologics's Long-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Y-Biologics (XKRX:338840) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Y-Biologics Inc (XKRX:338840) » Definitions » Long-Term Debt
Comparable Companies
Traded in Other Exchanges
N/A
Address
No. 715, 17, Tech-ro 4-ro, Yuseong-gu, Daejeon, KOR
Website
https://www.ybiologics.com
Y-Biologics Inc is a company has a variety of development candidate antibodies based on Korea's highest-level antibody discovery platform technology and then independently develops antibody treatments or jointly develops cutting-edge biopharmaceuticals by fusing them with our partner's platform technology. Its main business model is based on a globally competitive antibody discovery platform and consists of development of new bio drug candidates and early technology transfer, and contract research services that generate stable cash flow.

Y-Biologics (XKRX:338840) Headlines

No Headlines